Russian scientists have developed a drug designed to protect patients' bodies during radiation therapy. This was reported by Qazaqyia.kz citing Kursiv Media.
According to Andrey Kaprin, Director General of the National Medical Research Center of Radiology and Chief Oncologist of the Russian Ministry of Health, the drug aims to reduce negative effects on healthy tissues.
"One of the promising areas is the creation of a radioprotective drug intended to reduce the negative impact of ionizing radiation on the body. Such agents are especially in demand in radiation therapy, where our task is not only to effectively target the tumor but also to protect healthy tissues," the academician was quoted as saying.
Currently, the development is at the expert review stage, but initial results allow oncologists to assess its prospects with cautious optimism.
Earlier, Kursiv reported that Chinese regulators approved the commercial use of the drug satri-cel by CARsgen Therapeutics for gastric cancer treatment. CAR-T therapy modifies patients' immune cells to recognize and destroy cancer cells.
Previously, it was reported that in six patients in Kazakhstan participating in trials of an anti-cancer drug, tumor growth stopped, and in one patient the malignant tumor even shrank. The drug was developed by Kazakh scientists. Vice President of the National Academy of Sciences of Kazakhstan Dos Sarbasov spoke about the initial phases of the trials.
Kursiv also reported that the Kazakh anti-cancer drug will be tested on 5,000 patients in 2027-2029 if all previous stages are successful.
If the article causes anxiety, discuss it with an artificial psychologist.